Literature DB >> 10798085

Evaluation of bone mineral density in children with diabetes mellitus.

B Ersoy1, D Gökşen, S Darcan, E Mavi, C Oztürk.   

Abstract

Multiple studies have documented reduction in peripheral bone mass in children with insulin dependent diabetes mellitus (IDDM). In this study, the bone mineral density (BMD) of the lumbar vertebrae (L2-L4) was measured by dual photon absorptiometry in 14 female and 16 male diabetic patients of age 11 to 16 years with varying clinical duration. Twenty three children between 11 to 16 years with normal anthropometric measurements between 10th and 97th percentile and no known history of metabolic bone disease served as a control group. BMD values, weight, height, body mass index, metabolic, biochemical and growth parameters of the study group were compared with those of the control group. BMD (L2 AP 0.732 +/- 0.15 gm/cm2, L2 lateral 0.534 +/- 0.09 gm/cm2 in the study group and 0.812 +/- 0.63 gm/cm2 and 0.619 +/- 0.20 gm/cm2 in the control group) and osteocalcin (10.10 +/- 3.40 ng/ml and 23.12 +/- 2.74 ng/ml in diabetes and control respectively) levels were significantly lower in diabetic patients (p < 0.05, p < 0.01 respectively). Within the study group BMD correlated positively with age but not with the duration of the disease nor with the level of metabolic control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10798085     DOI: 10.1007/bf02845528

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

Review 1.  Clinical use of bone densitometry.

Authors:  C C Johnston; C W Slemenda; L J Melton
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

2.  Diminution of bone mass in childhood diabetes.

Authors:  A L Rosenbloom; D C Lezotte; F T Weber; J Gudat; D R Heller; M L Weber; S Klein; B B Kennedy
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

3.  Spinal bone mineral density in children aged 5.00 through 11.99 years.

Authors:  S W Ponder; D P McCormick; H D Fawcett; J L Palmer; M G McKernan; B H Brouhard
Journal:  Am J Dis Child       Date:  1990-12

4.  Alterations of bone and mineral metabolism in diabetes mellitus. Part II. Clinical studies in 206 patients with type I diabetes mellitus.

Authors:  F S Hough
Journal:  S Afr Med J       Date:  1987-07-18

5.  Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters.

Authors:  C Glastre; P Braillon; L David; P Cochat; P J Meunier; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

6.  Bone mineral density in the femur and lumbar vertebrae decreases after twelve weeks of diabetes in spontaneously diabetic-prone BB/Worcester rats.

Authors:  C E Waud; S C Marks; R Lew; D T Baran
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

7.  Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production.

Authors:  R Bouillon
Journal:  Verh K Acad Geneeskd Belg       Date:  1992

8.  Calcium homeostasis in diabetes mellitus.

Authors:  H Heath; P W Lambert; F J Service; S B Arnaud
Journal:  J Clin Endocrinol Metab       Date:  1979-09       Impact factor: 5.958

9.  A prospective study of bone mass in patients with type I diabetes.

Authors:  S L Hui; S Epstein; C C Johnston
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

10.  Secretion of osteocalcin and its propeptide from human osteoblastic cells: dissociation of the secretory patterns of osteocalcin and its propeptide.

Authors:  K Hosoda; S Kanzaki; H Eguchi; M Kiyoki; T Yamaji; Y Koshihara; M Shiraki; Y Seino
Journal:  J Bone Miner Res       Date:  1993-05       Impact factor: 6.741

View more
  7 in total

Review 1.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

Review 2.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

3.  Association between metabolic syndrome and bone mineral density in a Taiwanese elderly population.

Authors:  Song-Seng Loke; Hsueh-Wen Chang; Wen-Cheng Li
Journal:  J Bone Miner Metab       Date:  2017-03-16       Impact factor: 2.626

4.  Unaffected bone mineral density in Danish children and adolescents with type 1 diabetes.

Authors:  Jens Otto Broby Madsen; Camilla Winther Herskin; Bo Zerahn; Andreas Kryger Jensen; Niklas Rye Jørgensen; Birthe Susanne Olsen; Flemming Pociot; Jesper Johannesen
Journal:  J Bone Miner Metab       Date:  2019-11-21       Impact factor: 2.626

5.  Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.

Authors:  C Tsentidis; D Gourgiotis; L Kossiva; A Doulgeraki; A Marmarinos; A Galli-Tsinopoulou; K Karavanaki
Journal:  Osteoporos Int       Date:  2015-11-20       Impact factor: 4.507

6.  IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes.

Authors:  Laurie J Moyer-Mileur; Hillarie Slater; Kristine C Jordan; Mary A Murray
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

7.  Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Authors:  Shaymaa Abdalwahed Abdulameer; Syed Azhar Syed Sulaiman; Mohamed Azmi Ahmad Hassali; Karuppiah Subramaniam; Mohanad Naji Sahib
Journal:  Patient Prefer Adherence       Date:  2012-06-11       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.